Tuesday, June 5, 2012

Mesothelioma ? Photodynamic Therapy Yields Longer Survival Rates

Editor?s Choice
Academic Journal
Main Category: Asbestos / Mesothelioma
Also Included In: Lung Cancer
Article Date: 01 Jun 2012 ? 7:00 PDT

email to a friend ? printer friendly ? opinions ?

<!? rate article

Patient / Public:

4 (2 votes)

Healthcare Prof:

5 (1 votes)

Treating patients with malignant pleural mesothelioma with PDT (photodynamic therapy) alongside lung-sparing surgery appears to result in significantly longer survival rates ? up to two years longer compared to other treatments, and sometimes even more, researchers from the Perelman School of Medicine, University of Pennsylvania reported in Annals of Thoracic Surgey.

Mesothelioma is an extremely aggressive form of cancer and is typically caused by asbestos exposure. Experts say it is one of the deadliest forms of cancer. Asbestos exposure can result in the development of cancer 10 to 15 years later. However, only about 4 in every 10 patients survive more than a year after mesothelioma diagnosis.

Lead author, Joseph Friedberg, MD, said:

?While I don?t consider anything short of a cure as a victory against mesothelioma, I am encouraged by our results. Based on our new findings, we are redoubling our clinical and translational research efforts to find a way to further improve and refine this multimodality treatment approach for mesothelioma.?

In a previous study, the same team had shown that lung-sparing surgery plus photodynamic therapy was better for patients with mesothelioma than traditional treatment. Traditional treatment involved surgically removing a lung, whole chest radiation and chemotherapy.

38 patients, all of them with mesothelioma, underwent lung-sparing surgery and photodynamic therapy. In each case, a specialist decided whether they were suitable for lung-sparing surgery. All but one of them had advanced stage (III/IV) cancer. When they were followed up 34 months after the PDT plus lung-sparing surgery, the median overall survival rate was 31.7 months.

In 31 of the patients, the subtype of the cancer was a significant factor, the authors added. They had the epithelial subtype ? and their median overall survival was 41.2 months.

The authors explain that with mesothelioma patients, oncologists focus on extending their lives and improving quality of life. All patients with this type of cancer eventually experience recurrence ? the cancer comes back. If the patient can keep both lungs, they are in a better position to withstand additional treatment when the cancer comes back, and consequently live longer.


A beam of light travels along fiber optics for photodynamic therapy. The patient is given a photosensitive drug that is absorbed by cancer cells. The light beam is aimed at the tumor site, which activates the drugs, and destroys cancer cells

Friedberg said:

?We are working together as a team, not just in the clinic but in the laboratory as well, to find the best way to combine our respective expertise. Our goal is an innovative combined treatment that represents a new level of a multipronged attack on this horrendous cancer.?

Christian Nordqvist


Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Friedberg, Joseph S., Culligan, Melissa J., Mick, Rosemarie, Stevenson, James, Hahn, Stephen M., Sterman, Daniel, Punekar, Salman, Glatstein, Eli, Cengel, Keith
?Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma?
Ann Thorac Surg 2012 93: 1658-1667

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.


?Mesothelioma ? Photodynamic Therapy Yields Longer Survival Rates?

Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd ? 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

back to top | home |
privacy policy

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd ? 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Article source: http://www.medicalnewstoday.com/articles/246104.php


liam hemsworth hunger games miss canada justin bieber boyfriend marianas trench camille grammer camille grammer

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.